Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
Cobb
Leonard A
LA
Killip
Thomas
T
Lambrew
Costas T
CT
MacLeod
Bruce A
BA
Rackley
Charles E
CE
Selker
Harry P
HP
Zalenski
Robert J
RJ
D000925:Anticoagulants / Q000627:therapeutic use; D002314:Cardioplegic Solutions / Q000627:therapeutic use*; D005947:Glucose / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011188:Potassium / Q000627:therapeutic use*
D000925:Anticoagulants; D002314:Cardioplegic Solutions; D007328:Insulin; C030396:glucose-insulin-potassium cardioplegic solution; D006493:Heparin; D005947:Glucose; D011188:Potassium